---
title: "This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295938370.md"
description: "Wall Street analysts issued several upgrades on Friday. Key changes include Stifel upgrading Intuitive Machines to Buy, Cantor Fitzgerald raising Capricor Therapeutics to Overweight with a price target increase from $3.5 to $28, Keefe, Bruyette & Woods upgrading Nayax to Outperform, HSBC upgrading Digital Realty Trust to Buy, and Jefferies upgrading Minerva Neurosciences to Buy."
datetime: "2026-08-14T12:55:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295938370.md)
  - [en](https://longbridge.com/en/news/295938370.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295938370.md)
---

# This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Stifel analyst Jonathan Siegmann upgraded **Intuitive Machines Inc** (NASDAQ:LUNR) from Hold to Buy and lowered the price target from $32 to $26. Intuitive Machines closed at $17.56 on Thursday. See how other analysts view this stock.
-   Cantor Fitzgerald analyst Kristen Kluska upgraded **Capricor Therapeutics Inc** (NASDAQ:CAPR) from Neutral to Overweight and boosted the price target from $3.5 to $28. Capricor Therapeutics shares closed at $4.21 on Thursday. See how other analysts view this stock.
-   Keefe, Bruyette & Woods analyst Sanjay Sakhrani upgraded **Nayax Ltd** (NASDAQ:NYAX) from Market Perform to Outperform and maintained the price target of $75. Nayax closed at $53.49 on Thursday. See how other analysts view this stock.
-   HSBC analyst Phani Kanumuri upgraded **Digital Realty Trust Inc** (NYSE:DLR) from Hold to Buy and raised the price target from $210 to $240. Digital Realty Trust shares closed at $197.58 on Thursday. See how other analysts view this stock.
-   Jefferies analyst Biren Amin upgraded **Minerva Neurosciences, Inc** (NASDAQ:NERV) from Hold to Buy and raised the price target from $7.5 to $10. Minerva Neurosciences closed at $3.92 on Thursday. See how other analysts view this stock.

Considering buying CAPR stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [NERV.US](https://longbridge.com/en/quote/NERV.US.md)
- [LUNR.US](https://longbridge.com/en/quote/LUNR.US.md)
- [LUNRW.US](https://longbridge.com/en/quote/LUNRW.US.md)
- [DLR.US](https://longbridge.com/en/quote/DLR.US.md)
- [NYAX.US](https://longbridge.com/en/quote/NYAX.US.md)
- [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md)
- [LUNL.US](https://longbridge.com/en/quote/LUNL.US.md)

## Related News & Research

- [These Analysts Revise Their Forecasts On Intuitive Machines Following Q2 Results](https://longbridge.com/en/news/295932673.md)
- [Digital Realty Trust declares Q3 2026 distribution of R$ 0.26 per unit, payable Oct. 6](https://longbridge.com/en/news/295825838.md)
- [Capricor Therapeutics (CAPR) Could Be 89% Undervalued Following Deramiocel And Loss Concerns](https://longbridge.com/en/news/296098763.md)
- [Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit](https://longbridge.com/en/news/296500998.md)
- [06:15 ETCAPR Stock Alert: Capricor Therapeutics, Inc. (CAPR) Reports Q2 Earnings Amid Ongoing Securities Class Action Lawsuit - Hagens Berman](https://longbridge.com/en/news/296212321.md)